These findings are consistent with the literature that EP4 is upregulated in colorectal cancer [48] relative to normal colonic epithelium, malignant versus benign kidney cells [49], breast cancer [22], and castration-resistant hormone-naïve prostate cancer [50]. This evidence concerns the gene PTGER4 and breast cancer.